Treatment of inflammation with 5α reduced metabolites
US7790706B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2004 |
| Grant date | Sep 7, 2010 |
| Priority date | — |
| Expiry date | Apr 27, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/573
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the modulation of glucocorticoid metabolism. In particular the invention relates to the modulation of the functional activity of the glucocorticoid receptor by 5α reduced metabolic breakdown products of glucocorticoids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.